We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Jacobs (J) Wins Water Treatment Plant Contract From TasWater
Read MoreHide Full Article
Jacobs Engineering Group Inc. (J - Free Report) has received a design services contact from Australia’s primary water and sewage utility provider — TasWater. Per the contract, Jacobs will provide concept/functional design for estimating purposes, detailed design and construction and commissioning support services for TasWater's Bryn Estyn Water Treatment Plant (WTP) Upgrade project in Hobart, Australia.
Hobart is one of the driest capital cities in Australia despite having a relatively moderate climate. The project will adopt a new and multi-barrier approach to ensure safe drinking water supply within the city and increase capacity to 160 mega liters per day to meet future demand. TasWater estimates the upgrade cost to be more than $155 million.
Jacobs’ People & Places Solutions’ Executive Vice President Global Operations, Patrick Hill, said, "The quality of its drinking water supply has been impacted by recent lower than average rainfall at a time when demand is rising from a growing population. This makes this upgrade critical to ensure the reliability of drinking water for future generations."
Solid Project Execution: A Boon
Efficient project execution has been one of the main characteristics driving Jacobs’ performance over the last few quarters. The company’s ongoing contract wins are a testimony to the fact. For the fiscal second quarter, it reported a backlog of $15.5 billion, up 9.6% year over year. This reflects persistent solid demand for Jacobs' consulting services.
The company’s overall 18-month qualified new business pipeline of more than $30 billion remains robust. Jacobs is benefiting from well-funded government programs and cyber, U.S. Department of Defense or DoD, mission-IT, space, nuclear as well as 5G-related projects. In fact, it has worked for more than 10 years with Health Infrastructure to design world-leading, technology-forward and award-winning healthcare facilities for local communities.
Recently, its PP&S unit has inked a contract from Auckland Transport, New Zealand, to design, consent and construct three stages — 2, 3 and 4 — of the Eastern Busway project. The contract is valued at $455 million and is expected to be completed by 2025.
In June, Jacobs received a contract from National Industrial Corridor Development Corporation Limited to develop smart city masterplans for three greenfield industrial developments in South India. In the same month, it secured a new Architecture and Engineering contract to support the U.S. Air Force B-21 program. The contract has a base period of five years and an optional period of two years.
Image Source: Zacks Investment Research
Jacobs’ shares have gained 21.9% so far this year, almost in line with the industry’s 22.7% growth. Earnings estimates for 2021 have moved 5.2% upward in the past 60 days, depicting analysts’ optimism regarding the company’s growth potential.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Jacobs (J) Wins Water Treatment Plant Contract From TasWater
Jacobs Engineering Group Inc. (J - Free Report) has received a design services contact from Australia’s primary water and sewage utility provider — TasWater. Per the contract, Jacobs will provide concept/functional design for estimating purposes, detailed design and construction and commissioning support services for TasWater's Bryn Estyn Water Treatment Plant (WTP) Upgrade project in Hobart, Australia.
Hobart is one of the driest capital cities in Australia despite having a relatively moderate climate. The project will adopt a new and multi-barrier approach to ensure safe drinking water supply within the city and increase capacity to 160 mega liters per day to meet future demand. TasWater estimates the upgrade cost to be more than $155 million.
Jacobs’ People & Places Solutions’ Executive Vice President Global Operations, Patrick Hill, said, "The quality of its drinking water supply has been impacted by recent lower than average rainfall at a time when demand is rising from a growing population. This makes this upgrade critical to ensure the reliability of drinking water for future generations."
Solid Project Execution: A Boon
Efficient project execution has been one of the main characteristics driving Jacobs’ performance over the last few quarters. The company’s ongoing contract wins are a testimony to the fact. For the fiscal second quarter, it reported a backlog of $15.5 billion, up 9.6% year over year. This reflects persistent solid demand for Jacobs' consulting services.
The company’s overall 18-month qualified new business pipeline of more than $30 billion remains robust. Jacobs is benefiting from well-funded government programs and cyber, U.S. Department of Defense or DoD, mission-IT, space, nuclear as well as 5G-related projects. In fact, it has worked for more than 10 years with Health Infrastructure to design world-leading, technology-forward and award-winning healthcare facilities for local communities.
Recently, its PP&S unit has inked a contract from Auckland Transport, New Zealand, to design, consent and construct three stages — 2, 3 and 4 — of the Eastern Busway project. The contract is valued at $455 million and is expected to be completed by 2025.
In June, Jacobs received a contract from National Industrial Corridor Development Corporation Limited to develop smart city masterplans for three greenfield industrial developments in South India. In the same month, it secured a new Architecture and Engineering contract to support the U.S. Air Force B-21 program. The contract has a base period of five years and an optional period of two years.
Jacobs’ shares have gained 21.9% so far this year, almost in line with the industry’s 22.7% growth. Earnings estimates for 2021 have moved 5.2% upward in the past 60 days, depicting analysts’ optimism regarding the company’s growth potential.
Zacks Rank
Jacobs — which shares space with Quanta Services, Inc. (PWR - Free Report) , AECOM (ACM - Free Report) and KBR, Inc. (KBR - Free Report) in the Zacks Engineering - R and D Services industry — currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>